- Home
- SMX vs HOTH Comparison
SMX vs HOTH Comparison
Compare SMX & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMX
- HOTH
- Stock Information
- Founded
- SMX N/A
- HOTH 2017
- Country
- SMX Ireland
- HOTH United States
- Employees
- SMX N/A
- HOTH N/A
- Industry
- SMX Industrial Machinery/Components
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- SMX Technology
- HOTH Health Care
- Exchange
- SMX Nasdaq
- HOTH Nasdaq
- Market Cap
- SMX 19.2M
- HOTH 15.6M
- IPO Year
- SMX N/A
- HOTH 2019
- Fundamental
- Price
- SMX $1.30
- HOTH $1.60
- Analyst Decision
- SMX
- HOTH Strong Buy
- Analyst Count
- SMX 0
- HOTH 3
- Target Price
- SMX N/A
- HOTH $4.00
- AVG Volume (30 Days)
- SMX 3.3M
- HOTH 1.4M
- Earning Date
- SMX 01-01-0001
- HOTH 11-11-2025
- Dividend Yield
- SMX N/A
- HOTH N/A
- EPS Growth
- SMX N/A
- HOTH N/A
- EPS
- SMX N/A
- HOTH N/A
- Revenue
- SMX N/A
- HOTH N/A
- Revenue This Year
- SMX N/A
- HOTH N/A
- Revenue Next Year
- SMX N/A
- HOTH N/A
- P/E Ratio
- SMX N/A
- HOTH N/A
- Revenue Growth
- SMX N/A
- HOTH N/A
- 52 Week Low
- SMX $1.10
- HOTH $0.65
- 52 Week High
- SMX $2,296.30
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- SMX 40.53
- HOTH 51.02
- Support Level
- SMX $1.22
- HOTH $1.46
- Resistance Level
- SMX $1.41
- HOTH $1.62
- Average True Range (ATR)
- SMX 0.17
- HOTH 0.13
- MACD
- SMX 0.07
- HOTH -0.04
- Stochastic Oscillator
- SMX 21.74
- HOTH 24.43
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).